MetriSense
MetriSense provides a rapid point-of-care test that simultaneously measures leptin, adiponectin, and insulin from a single sample using lateral flow assay technology with europium fluorescent particle detection. Results are available in under 30 minutes without laboratory infrastructure, enabling same-visit metabolic assessments for insulin resistance, metabolic syndrome, and subclinical inflammation. The device requires no centrifugation or special refrigeration and can be operated by non-specialized staff after 10–20 minutes of training.
- Medical Devices
- Healthcare Technology
- Biotechnology
- Hardware
Funding
Founders
Founder details are not available yet.
Product
Problem
Detecting insulin resistance, metabolic syndrome, or subclinical inflammation currently requires centralized laboratory testing, patient travel, and wait times of up to three weeks. No commercial rapid test exists that measures leptin or adiponectin in a portable format, delaying preventive care decisions.
Solution
MetriSense offers the first rapid point-of-care test that simultaneously measures leptin, adiponectin, and insulin from a single sample. The platform uses lateral flow assay technology with europium (Eu³⁺) fluorescent particle detection and high-affinity antibodies to capture all three biomarkers at once. Results are available in less than 30 minutes, allowing clinicians to make preventive treatment decisions during the same consultation. The device requires no centrifugation, no special refrigeration, and can be operated by non-specialized staff after 10–20 minutes of training. No other portable device measures these three biomarkers in a single cassette.
Target Audience
Primary customers are physicians, clinic administrators, and distributors in Mexico seeking rapid metabolic diagnostics for insulin resistance, metabolic syndrome, and subclinical inflammation screening.
Features
- Single-cassette multiplex detection of leptin, adiponectin, and insulin using LFA with europium (Eu³⁺) fluorescent particle technology
- Results in under 30 minutes with no laboratory infrastructure required
- No centrifugation or special refrigeration needed; operable by non-specialized personnel after 10–20 minutes of training
- Point-of-care design enabling same-visit clinical decision-making
- Cost savings of 56%+ versus laboratory testing with a 2-month payback period for clinics